UBS ASSET MANAGEMENT AMERICAS INC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$746,527
+52.7%
81,856
+104.8%
0.00%
Q2 2023$488,8220.0%39,9690.0%0.00%
Q1 2023$488,822
-14.2%
39,969
-13.0%
0.00%
Q4 2022$569,855
-99.9%
45,9190.0%0.00%
Q3 2022$627,253,000
-89.9%
45,919
-86.5%
0.00%
-100.0%
Q2 2022$6,240,670,000
+10.7%
340,462
-2.9%
0.00%
+50.0%
Q1 2022$5,636,537,000
+8.3%
350,531
-5.7%
0.00%0.0%
Q4 2021$5,204,500,000
-27.5%
371,750
-3.0%
0.00%
-33.3%
Q3 2021$7,176,120,000
-12.3%
383,135
-2.4%
0.00%
-25.0%
Q2 2021$8,187,024,000
-3.5%
392,663
+30.9%
0.00%0.0%
Q1 2021$8,480,321,000
+0.1%
299,976
+15.7%
0.00%0.0%
Q4 2020$8,469,260,000
+614.2%
259,316
+570.1%
0.00%
+300.0%
Q3 2020$1,185,768,000
+90.2%
38,700
+1.2%
0.00%
Q2 2020$623,311,000
+303.7%
38,240
+146.5%
0.00%
Q1 2020$154,385,000
-52.8%
15,516
-34.8%
0.00%
Q4 2019$327,155,000
-8.9%
23,793
+0.5%
0.00%
Q3 2019$359,104,00023,6720.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders